Oxford BioDynamics Plc (OBD.L) • LSE
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
You don't hold OBD.L in your mock portfolio yet.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
The negative EPS and resulting negative P/E ratio indicate that Oxford BioDynamics Plc is currently loss-making and not generating positive net income. Without evidence of strong revenue growth or improving margins, the current financial profile points to ongoing profitability challenges and execution risk.
At $0.18, the stock trades materially below its 200-day moving average of $0.31, confirming a pronounced downtrend. The 17.8% decline over the last month reinforces weak price momentum and suggests sentiment is currently negative, with the stock underperforming its own longer-term trend.
Web traffic of roughly 9,965 visitors per month and modest growth across social channels suggest a small but slowly expanding digital footprint. However, the scale of engagement remains limited, and the absence of job openings points to either tight cost control or constrained growth investment, making these signals more neutral than clearly positive.
Overall, the combination of loss-making fundamentals, a sharply negative price trend, and only modest alternative data traction leads to a bearish stance on Oxford BioDynamics Plc at present. While incremental growth in online and social presence is a mild positive, it is not strong enough to offset the technical weakness and lack of profitability.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started